These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 2009099)
21. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates. Pistolozzi M; Du H; Wei H; Tan W Drug Metab Dispos; 2015 Mar; 43(3):344-52. PubMed ID: 25504505 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives. Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279 [TBL] [Abstract][Full Text] [Related]
23. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Duysen EG; Li B; Darvesh S; Lockridge O Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517 [TBL] [Abstract][Full Text] [Related]
24. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases. Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273 [TBL] [Abstract][Full Text] [Related]
25. Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors. Bosak A; Gazić Smilović I; Sinko G; Vinković V; Kovarik Z J Med Chem; 2012 Aug; 55(15):6716-23. PubMed ID: 22817559 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors. Ekiz M; Tutar A; Ökten S; Bütün B; Koçyiğit ÜM; Taslimi P; Topçu G Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800167. PubMed ID: 30079554 [TBL] [Abstract][Full Text] [Related]
27. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1. Ali MY; Seong SH; Jung HA; Jannat S; Choi JS Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040 [TBL] [Abstract][Full Text] [Related]
28. Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases. Gao D; Zhan CG J Phys Chem B; 2005 Dec; 109(48):23070-6. PubMed ID: 16854005 [TBL] [Abstract][Full Text] [Related]
29. The interaction of amiloride with acetylcholinesterase and butyrylcholinesterase. Zemach L; Segal D; Shalitin Y FEBS Lett; 1990 Apr; 263(1):166-8. PubMed ID: 2332047 [TBL] [Abstract][Full Text] [Related]
30. Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. Zhan CG; Zheng F; Landry DW J Am Chem Soc; 2003 Mar; 125(9):2462-74. PubMed ID: 12603134 [TBL] [Abstract][Full Text] [Related]
31. Cocaine and butyrylcholinesterase (BChE): determination of enzymatic parameters. Mattes C; Bradley R; Slaughter E; Browne S Life Sci; 1996; 58(13):PL257-61. PubMed ID: 8622553 [TBL] [Abstract][Full Text] [Related]
32. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase. Bartling A; Worek F; Szinicz L; Thiermann H Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809 [TBL] [Abstract][Full Text] [Related]
33. Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates. Krátký M; Štěpánková Š; Vorčáková K; Švarcová M; Vinšová J Molecules; 2016 Feb; 21(2):. PubMed ID: 26875979 [TBL] [Abstract][Full Text] [Related]
34. Mechanism of aging of mipafox-inhibited butyrylcholinesterase. Kropp TJ; Richardson RJ Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978 [TBL] [Abstract][Full Text] [Related]
35. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors. Krátký M; Štěpánková Š; Vorčáková K; Vinšová J Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597 [TBL] [Abstract][Full Text] [Related]
37. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity. Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656 [TBL] [Abstract][Full Text] [Related]
38. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases. Khalid A; Zaheer-ul-Haq ; Anjum S; Khan MR; Atta-ur-Rahman ; Choudhary MI Bioorg Med Chem; 2004 May; 12(9):1995-2003. PubMed ID: 15080903 [TBL] [Abstract][Full Text] [Related]
39. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline. Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of two different cholinesterases by tacrine. Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]